BriaCell Therapeutics (TSE:BCT) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
BriaCell Therapeutics announced a share consolidation plan, converting every fifteen pre-consolidation shares into one post-consolidation share to meet Nasdaq listing requirements. The consolidation, effective January 24, 2025, will see the new shares trading from January 29, 2025, ensuring continued compliance and adjusted securities pricing.
For further insights into TSE:BCT stock, check out TipRanks’ Stock Analysis page.